Brynjelsen Sean's Form 4 filing
Eton Pharmaceuticals, Inc. (ETON) · filed Jul 14, 2026
- Accession no.
- 0001437749-26-023570
- Filed
- Jul 14, 2026, 5:28 PM ET
- Trade date
- Jul 12-14, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brynjelsen SeanCIK 0001669976 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 12, 2026 | Common Stock | MOption exerciseAcquired | +27,500 | – | – | 861,194 | Direct | |
| Jul 14, 2026 | Common Stock | MOption exerciseAcquired | +200,000 | $1.37 | +$274,000 | 1,061,194 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 12, 2026 | Common Stock | MOption exerciseDisposed | −27,500 | $0.00 | $0 | 0 | Direct | |
| Jul 14, 2026 | Common Stock | MOption exerciseAcquired | +200,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.